NewsMakers in the Biotech Industry Conference to Webcast Millennium Presentation

NewsMakers in the Biotech Industry Conference to Webcast Millennium Presentation

CAMBRIDGE, Mass., Sept. 2 /PRNewswire-FirstCall/ -- Millennium Pharmaceuticals, Inc. (NASDAQ:MLNM) today announced that its presentation at the NewsMakers in the Biotech Industry Conference will be webcast live and may be accessed by visiting the Investors section of the Company's website, http://www.millennium.com/.

(Photo: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO )

Millennium senior management will provide an overview of the Company and upcoming corporate events. The presentation will be delivered at 1:20 p.m. ET on Friday, September 9, 2005 from the Sheraton New York Hotel & Towers in New York City. The presentation will be archived for 30 days.

About Millennium

Millennium Pharmaceuticals, Inc., a leading biopharmaceutical company based in Cambridge, Mass., markets VELCADE(R) (bortzeomib) Injection, a novel cancer product, and has a robust clinical development pipeline of product candidates. The Company's research, development and commercialization activities are focused in three therapeutic areas: oncology, inflammation, and cardiovascular. By applying its knowledge of the human genome, its understanding of disease mechanisms and its industrialized drug discovery platform, Millennium is seeking to develop breakthrough products. The Company's website is http://www.millennium.com/.

Editors' Note: This press release is also available under the Media section of the Company's website at: http://www.millennium.com/.

Contact:
Kyle Kuvalanka
(617) 761-4734

Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/19991220/MLNMLOGO
AP Archive: http://photoarchive.ap.org/
PRN Photo Desk photodesk@prnewswire.com
Source: Millennium Pharmaceuticals, Inc.

CONTACT: Kyle Kuvalanka of Millennium Pharmaceuticals, Inc.,
+1-617-761-4734

Web site: http://www.millennium.com/

Company News On-Call: http://www.prnewswire.com/comp/114562.html

-------
Profile: jene29